Zymeworks Inc ZYME:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/15/24 EDT
9.15UNCH (UNCH)
Volume
358,677
Close
9.15UNCH (UNCH)
Volume
493,147
52 week range
6.01 - 13.14
Loading...
  • Open9.17
  • Day High9.56
  • Day Low9.01
  • Prev Close9.00
  • 52 Week High13.14
  • 52 Week High Date02/27/24
  • 52 Week Low6.01
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap646.95M
  • Shares Out70.70M
  • 10 Day Average Volume0.86M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change-11.93

KEY STATS

  • Open9.17
  • Day High9.56
  • Day Low9.01
  • Prev Close9.00
  • 52 Week High13.14
  • 52 Week High Date02/27/24
  • 52 Week Low6.01
  • 52 Week Low Date10/04/23
  • Market Cap646.95M
  • Shares Out70.70M
  • 10 Day Average Volume0.86M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change-11.93

RATIOS/PROFITABILITY

  • EPS (TTM)-1.79
  • P/E (TTM)-5.12
  • Fwd P/E (NTM)-8.52
  • EBITDA (TTM)-138.91M
  • ROE (TTM)-27.64%
  • Revenue (TTM)50.464M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-249.63%
  • Debt To Equity (MRQ)0.02%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zymeworks Inc

 

Profile

MORE
Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop differentiated antibody-based therapeutic candidates. Its platforms include Azymetric, Drug Conjugate Platforms...
Kenneth Galbraith
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Address
108 Patriot Drive, Suite A
Middletown, DE
19709
United States

Top Peers

SYMBOLLASTCHG%CHG
ANAB
AnaptysBio Inc
25.60UNCHUNCH
EXAI
Exscientia PLC
5.13UNCHUNCH
OABI
OmniAb Inc
4.54UNCHUNCH
STOK
Stoke Therapeutics Inc
14.13UNCHUNCH
LYEL
Lyell Immunopharma Inc
2.61UNCHUNCH